News | March 07, 2025
Medicamen Biotech partners with South African business conglomerate
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The inspection was successfully completed
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Subscribe To Our Newsletter & Stay Updated
